PTLA - Portola Pharmaceuticals - This Name You Haven't Heard Of Is The Next Big COVID-19 Company
Portola Pharmaceuticals (NASDAQ: PTLA) is a $1.4 billion corporation that was recently acquired by Alexion Pharmaceuticals (NASDAQ: ALXN). The two companies entered a definitive merger agreement, which we discussed and recommend reading about here. As we'll see throughout this article, recent COVID-19 news could be a massive boon to Portola Pharmaceuticals business.
COVID-19 and Blood Clots
The first aspect of the business we want to discuss is the rapid increase in blood clots as a result of COVID-19.
A blood clot is fundamentally